Andrew John Nicol

发表论文 94 篇 · 总被引 3407 次 · h-index 29

代表论文

Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial (2019 · The Lancet Haematology · 被引 259)
Pembrolizumab plus lenalidomide and dexamethasone for patients with treatment-naive multiple myeloma (KEYNOTE-185): a randomised, open-label, phase 3 trial (2019 · The Lancet Haematology · 被引 249)
Clinical evaluation of autologous gamma delta T cell-based immunotherapy for metastatic solid tumours (2011 · British Journal of Cancer · 被引 247)
Clinical and immunological evaluation of zoledronate-activated Vγ9γδ T-cell-based immunotherapy for patients with multiple myeloma (2009 · Experimental Hematology · 被引 171)
Chemotherapy and zoledronate sensitize solid tumour cells to Vγ9Vδ2 T cell cytotoxicity (2007 · Cancer Immunology Immunotherapy · 被引 161)
Vγ9Vδ2 T cell cytotoxicity against tumor cells is enhanced by monoclonal antibody drugs—Rituximab and trastuzumab (2008 · International Journal of Cancer · 被引 154)